DE602004027088D1 - Verfahren zur herstellung von benzimidazolen - Google Patents

Verfahren zur herstellung von benzimidazolen

Info

Publication number
DE602004027088D1
DE602004027088D1 DE602004027088T DE602004027088T DE602004027088D1 DE 602004027088 D1 DE602004027088 D1 DE 602004027088D1 DE 602004027088 T DE602004027088 T DE 602004027088T DE 602004027088 T DE602004027088 T DE 602004027088T DE 602004027088 D1 DE602004027088 D1 DE 602004027088D1
Authority
DE
Germany
Prior art keywords
salts
benzimidazolene
preparation
reconstitutable
discloses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004027088T
Other languages
English (en)
Inventor
Mannalal Ramgopal Bajaj
Rajan Shantaram Samant
Bharat Babulal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LYKA LABS Ltd
Original Assignee
LYKA LABS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34746668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004027088(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LYKA LABS Ltd filed Critical LYKA LABS Ltd
Publication of DE602004027088D1 publication Critical patent/DE602004027088D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
DE602004027088T 2003-11-05 2004-11-03 Verfahren zur herstellung von benzimidazolen Active DE602004027088D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1164MU2003 2003-11-05
PCT/IN2004/000342 WO2005065682A2 (en) 2003-11-05 2004-11-03 Rabeprazole containing formulation

Publications (1)

Publication Number Publication Date
DE602004027088D1 true DE602004027088D1 (de) 2010-06-17

Family

ID=34746668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004027088T Active DE602004027088D1 (de) 2003-11-05 2004-11-03 Verfahren zur herstellung von benzimidazolen

Country Status (11)

Country Link
US (1) US20070014875A1 (de)
EP (1) EP1713476B1 (de)
AT (1) ATE466579T1 (de)
BR (1) BRPI0416027A (de)
CY (1) CY1110717T1 (de)
DE (1) DE602004027088D1 (de)
DK (1) DK1713476T3 (de)
ES (1) ES2344905T3 (de)
PL (1) PL1713476T3 (de)
PT (1) PT1713476E (de)
WO (1) WO2005065682A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0711048A2 (pt) * 2006-05-09 2011-08-23 Astrazeneca Ab formulações parenteral esterilizada e sólida estáveis, solução para administração parenteral, processos para a preparação de uma formulação e para a fabricação de um produto, método para prevenir ou tratar doenças gastrintestinais, uso de uma formulação sólida estável
CN102138907A (zh) * 2010-02-02 2011-08-03 南京长澳医药科技有限公司 一种稳定的雷贝拉唑钠冻干制剂及其制备方法
CN103463636B (zh) * 2013-09-17 2015-05-27 天津市嵩锐医药科技有限公司 一种供注射用的泮托拉唑钠药物组合物
MA41623A (fr) * 2015-11-26 2018-01-09 Verano Ilac Sanayi Ve Ticaret A S Composition lyophilisée de composé de benzimidazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0651727T3 (da) * 1992-07-20 1997-10-13 Unilever Plc Fremstilling af gashydrater.
ES2093445T3 (es) * 1992-07-28 1996-12-16 Astra Ab Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
TW280770B (de) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
US7396841B2 (en) * 2000-08-18 2008-07-08 Takeda Pharmaceutical Company Limited Injections

Also Published As

Publication number Publication date
BRPI0416027A (pt) 2007-01-02
US20070014875A1 (en) 2007-01-18
ATE466579T1 (de) 2010-05-15
EP1713476B1 (de) 2010-05-05
PT1713476E (pt) 2010-08-04
WO2005065682A3 (en) 2005-09-01
ES2344905T3 (es) 2010-09-09
CY1110717T1 (el) 2015-06-10
DK1713476T3 (da) 2010-08-09
EP1713476A2 (de) 2006-10-25
PL1713476T3 (pl) 2010-10-29
WO2005065682A2 (en) 2005-07-21

Similar Documents

Publication Publication Date Title
CY1121877T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει πιμοβενδανη
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
WO2008057802A3 (en) Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
CY1112211T1 (el) Σταθερο στην αποθηκευση διαλυμα διυδροπτεριδινονων για εγχυση
EA200400154A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
CY1111159T1 (el) Πυκνα διαλυματα μεθοτρεξατης
EA200970047A1 (ru) Водные суспензии тмс278
GEP20146177B (en) Pyrazole compounds as crth2 antagonists
EA200870302A1 (ru) 1,3-диоксанкарбоновые кислоты
EA201071409A1 (ru) Новые соли (4-{[(5-{[(3-хлорфенил)метил]окси}-2-метилфенил)карбонил]амино}-3-метилфенил)уксусной кислоты
CY1107461T1 (el) Νεα μεθοδος διαπιδυσης
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
DE602007011384D1 (de) Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure
EA032938B1 (ru) Производное глутаримидов, его применение, фармацевтическая композиция на его основе, способ его получения
DE60335279D1 (de) Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem
ATE528301T1 (de) Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
DE602005016282D1 (de) Verfahren zur herstellung von camptothecin-derivaten
CY1110717T1 (el) Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли
EA201291401A1 (ru) НОВЫЕ ПРОТИВОГРИБКОВЫЕ ПРОИЗВОДНЫЕ 5,6-ДИГИДРО-4-[(ДИФТОРЭТИЛ)ФЕНИЛ]-4H-ПИРРОЛО[1,2-a][1,4]БЕНЗОДИАЗЕПИНА И 4-(ДИФТОРЭТИЛ)ФЕНИЛ-6H-ПИРРОЛО[1,2-a][1,4]БЕНЗОДИАЗЕПИНА
ATE543812T1 (de) Verfahren zur herstellung von candesartan- cilexetil
MY150988A (en) Novel derivatives of ( bridged piperazinyl)-1-alkanone and use thereof as p75 inhibitors

Legal Events

Date Code Title Description
8363 Opposition against the patent